Ranjit Bindra,MD/PhD
7.2K posts

Ranjit Bindra,MD/PhD
@ranjitbindra
Harvey & Kate Cushing Professor at Yale; Co-Director, Yale Brain Tumor Center; CNS RadOnc; Biotech Entrepreneur; Surprisingly good drummer…




~25–30% of #AML has MGMT silencing—a targetable vulnerability. New research presented by @Prateek_Bhardwj identifies KL50, a novel crosslinking compound, as highly potent in MGMT-silenced AML. The data shared #ASH25 strongly supports MGMT-guided clinical trials of KL50. @Halene_lab @ranjitbindra @YaleHematology @ASH_hematology


Yale Therapeutic Radiology has made it to #ASTRO25! Excited to learn, collaborate, and showcase our own work in the great city of San Francisco! 🌁



Honored to receive this award! Grateful to @YalePediatrics @YaleCancer @SmilowCancer and to past and current mentors, particularly @ranjitbindra for their support. Excited to move forward in developing new therapies for children with cancer!

James Elia @yalepathology has been awarded a prestigious Ruth L. Kirschstein Predoctoral Individual National Research Service Award #F31 from @NIH for his project, “Exploiting Homologous Recombination Defects with a Novel DNA-Crosslinking Strategy.” yalecancercenter.org/news-article/p… @SmilowCancer @ranjitbindra

James Elia @yalepathology has been awarded a prestigious Ruth L. Kirschstein Predoctoral Individual National Research Service Award #F31 from @NIH for his project, “Exploiting Homologous Recombination Defects with a Novel DNA-Crosslinking Strategy.” yalecancercenter.org/news-article/p… @SmilowCancer @ranjitbindra



Grateful to be promoted to full professor @YaleMed! I truly appreciate all the support along the way, including from countless mentors, colleagues, letter writers, trainees, friends, and family, especially my parents and wife. I plan to pay it forward! @YaleCancer @YaleRadOnc


Had an amazing time at @YaleCancer 8th annual symposium! I had the honor of presenting our work on NAPRT-loss in pediatric rhabdomyosarcoma. All thanks to my amazing mentors, @JcvasqV and @ranjitbindra, as well as all the collaborators 🙌 @Shahyan_Rehman @yalepathology





New research led by James Elia #BindraLab @ranjitbindra, led to development of a pioneering, free software application #CellPyAbility, a tool to simplify + enhance analysis of cell viability data. yalecancercenter.org/news-article/m… @SmilowCancer @YaleMed @YNHH #NCRM25 #unitedbycancerresearch @AACR
